$RELI
Reliance Global Group, Inc. Stock $reli

$reli Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224013118 Filed on April 04, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$3.233M	$3.321M	$13.73M
YoY Change	1.17%	-20.16%	-18.05%
Cost Of Revenue	$886.4K	$1.031M	$3.733M
YoY Change	7.79%	34.36%	10.29%
Gross Profit	$2.347M	$2.290M	$9.999M
YoY Change	-1.12%	-32.49%	-25.22%
Gross Profit Margin	72.59%	68.95%	72.82%
Selling, General & Admin	$3.024M	$2.273M	$11.96M
YoY Change	-14.98%	-45.01%	-33.18%
% of Gross Profit	128.84%	99.26%	119.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$469.8K	$649.2K	$2.609M
YoY Change	-38.78%	-10.39%	-6.88%
% of Gross Profit	20.02%	28.35%	26.09%
Operating Expenses	$4.380M	$2.920M	$14.57M
YoY Change	-12.99%	-39.89%	-62.12%
Operating Profit	-$1.147M	-$630.2K	-$4.568M
YoY Change	-37.62%	-57.0%	-78.95%
Interest Expense	-$403.5K	-$404.9K	-$1.656M
YoY Change	8.79%
% of Operating Profit
Other Income/Expense, Net	-$342.8K	$1.458M	$5.510M
YoY Change	-83.13%	-139.91%	-80.44%
Pretax Income	-$1.489M	-$8.888M	-$10.03M
YoY Change	-61.51%	-54.4%	-255.04%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$1.489M	-$11.57M	-$14.55M
YoY Change	41.14%	-40.66%	-325.01%
Net Earnings / Revenue	-46.06%	-348.27%	-105.96%
Basic Earnings Per Share	-$2.76		-$5.16
Diluted Earnings Per Share	-$2.76	-$2.91	-$5.15
COMMON SHARES
Basic Shares Outstanding	5.692M shares	2.474M shares	2.820M shares
Diluted Shares Outstanding	539.1K shares		2.820M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.406M	$1.329M	$1.329M
YoY Change	10.28%	162.96%	162.96%
Cash & Equivalents	$2.816M	$2.739M
Short-Term Investments
Other Short-Term Assets	$1.796M	$1.744M	$1.744M
YoY Change	-8.31%	5.44%	5.44%
Inventory
Prepaid Expenses
Receivables	$953.3K	$1.305M	$1.305M
Other Receivables	$167.3K	$900.00	$900.00
Total Short-Term Assets	$4.322M	$4.379M	$4.379M
YoY Change	-39.4%	34.12%	34.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$140.5K	$879.8K	$879.8K
YoY Change	-5.77%	370.79%	-35.73%
Goodwill	$6.693M	$6.693M
YoY Change	-53.15%	-64.98%
Intangibles	$6.153M	$11.04M
YoY Change	-50.01%	-19.73%
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$21.79K	$20.29K	$20.29K
YoY Change	-6.41%	-12.86%	-12.88%
Total Long-Term Assets	$14.02M	$18.64M	$18.64M
YoY Change	-49.46%	-47.0%	-47.0%
TOTAL ASSETS
Total Short-Term Assets	$4.322M	$4.379M	$4.379M
Total Long-Term Assets	$14.02M	$18.64M	$18.64M
Total Assets	$18.34M	$23.02M	$23.02M
YoY Change	-47.4%	-40.11%	-40.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.421M	$635.3K	$635.3K
YoY Change	55.91%	-47.98%	-47.98%
Accrued Expenses	$263.4K	$485.3K	$485.3K
YoY Change	-28.98%	269.53%	-35.69%
Deferred Revenue
YoY Change
Short-Term Debt	$108.5K	$56.20K	$56.20K
YoY Change	-44.35%	-63.51%	-63.51%
Long-Term Debt Due	$1.471M	$1.846M	$1.846M
YoY Change	10.69%	64.98%	64.98%
Total Short-Term Liabilities	$3.722M	$3.190M	$3.190M
YoY Change	-23.49%	-59.07%	-59.07%
LONG-TERM LIABILITIES
Long-Term Debt	$10.29M	$11.92M	$11.92M
YoY Change	-12.14%	-3.44%	-14.94%
Other Long-Term Liabilities	$781.9K	$753.3K	$753.3K
YoY Change	-82.21%	-90.22%	-90.22%
Total Long-Term Liabilities	$10.29M	$12.68M	$12.68M
YoY Change	-12.14%	2.66%	-41.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.722M	$3.190M	$3.190M
Total Long-Term Liabilities	$10.29M	$12.68M	$12.68M
Total Liabilities	$15.45M	$15.87M	$15.87M
YoY Change	-29.27%	-46.24%	-46.24%
SHAREHOLDERS EQUITY
Retained Earnings	-$45.84M	-$39.00M
YoY Change	53.63%	44.49%
Common Stock	$89.18K	$409.5K
YoY Change	-49.48%	290.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.889M	$7.147M	$7.147M
YoY Change
Total Liabilities & Shareholders Equity	$18.34M	$23.02M	$23.02M
YoY Change	-47.4%	-40.11%	-40.11%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.489M	-$11.57M	-$14.55M
YoY Change	41.14%	-40.66%	-325.01%
Depreciation, Depletion And Amortization	$469.8K	$649.2K	$2.609M
YoY Change	-38.78%	-10.39%	-6.88%
Cash From Operating Activities	-$685.2K	-$828.0K	-$848.0K
YoY Change	-27.28%	-18.18%	-73.42%
INVESTING ACTIVITIES
Capital Expenditures	$7.090K	$9.810K	$189.8K
YoY Change	-91.59%	-91.06%	166.54%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$900.0K
YoY Change		-100.0%	-103.8%
Cash From Investing Activities	-$7.090K	-$9.810K	$710.2K
YoY Change	-100.85%	-102.88%	-102.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$4.475M
YoY Change			209883.58%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.395M	386.9K	966.9K
YoY Change	-282.76%	-187.31%	-96.15%
NET CHANGE
Cash From Operating Activities	-685.2K	-828.0K	-848.0K
Cash From Investing Activities	-7.090K	-9.810K	710.2K
Cash From Financing Activities	1.395M	386.9K	966.9K
Net Change In Cash	702.6K	-450.9K	829.1K
YoY Change	-180.39%	-59.56%	-130.58%
FREE CASH FLOW
Cash From Operating Activities	-$685.2K	-$828.0K	-$848.0K
Capital Expenditures	$7.090K	$9.810K	$189.8K
Free Cash Flow	-$692.3K	-$837.8K	-$1.038M
YoY Change	-32.56%	-25.31%	-68.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2023Q4	us-gaap	Investments Investments		usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent		usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	RELI	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		shares
CY2022	RELI	Stock Issued During Period Value Issuance Of Series C Warrants In Exchange For Common Shares StockIssuedDuringPeriodValueIssuanceOfSeriesCWarrantsInExchangeForCommonShares		usd
CY2022	RELI	Stock Issued During Period Value For Vested Stock Awards StockIssuedDuringPeriodValueForVestedStockAwards		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2023	RELI	Proceeds From Loan Acquired Through Acquisition ProceedsFromLoanAcquiredThroughAcquisition		usd
CY2023	RELI	Isusance Of Common Shares In Exchange For Series B Warrants IsusanceOfCommonSharesInExchangeForSeriesBWarrants		usd
CY2023	RELI	Isusance Of Common Shares In Exchange For Series C Warrants IsusanceOfCommonSharesInExchangeForSeriesCWarrants		usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	RELI	Common Shares Issued For Earnout Liabilities CommonSharesIssuedForEarnoutLiabilities		usd
CY2023	RELI	Common Shares Issued For Series D Warrants CommonSharesIssuedForSeriesDWarrants		usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	RELI	Common Stock Issued For Prepaid Assets CommonStockIssuedForPrepaidAssets		usd
CY2023	RELI	Issuance Of Series D Warrants IssuanceOfSeriesDWarrants		usd
CY2023	RELI	Issuance Of Placement Agent Warrants IssuanceOfPlacementAgentWarrants		usd
CY2022	RELI	Earnout Payable In Common Shares EarnoutPayableInCommonShares		usd
CY2022	RELI	Earnout Transferred To Loans Payable Related Parties EarnoutTransferredToLoansPayableRelatedParties		usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	RELI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023	RELI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Expired Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrExpiredIntrinsicValue		usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	RELI	Share Based Compensation Arrangement By Share Based Payment Award Exercised Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisedGrantedIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	RELI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022	RELI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Expired Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrExpiredIntrinsicValue		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	RELI	Share Based Compensation Arrangement By Share Based Payment Award Exercised Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisedGrantedIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares		shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares		shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023	RELI	Effect Of Weighted Average Vested Stock Awards EffectOfWeightedAverageVestedStockAwards		shares
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 105
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Lakewood
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08701
CY2023	dei	City Area Code CityAreaCode	(732)
CY2023	dei	Local Phone Number LocalPhoneNumber	380-4600
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	7800000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5692387	shares
CY2023	dei	Auditor Firm AuditorFirmId	339
CY2023	dei	Auditor Name AuditorName	Mazars USA LLP
CY2023	dei	Auditor Location AuditorLocation	Washington, Pennsylvania
CY2023Q4	us-gaap	Cash Cash	1329016	usd
CY2022Q4	us-gaap	Cash Cash	505410	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1409895	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1404359	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	899	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	11464	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	333756	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	245535	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	85998	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4379032	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3265379	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139999	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	162767	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	739830	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1018952	usd
CY2022Q4	us-gaap	Investments Investments	900000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11042757	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13439369	usd
CY2023Q4	us-gaap	Goodwill Goodwill	6693099	usd
CY2022Q4	us-gaap	Goodwill Goodwill	14287099	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20292	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23284	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	5330879	usd
CY2023Q4	us-gaap	Assets Assets	23015009	usd
CY2022Q4	us-gaap	Assets Assets	38427729	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-26066129	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	56197	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	154017	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	835483	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	951382	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	7414	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	101113	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1390766	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1118721	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	285171	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339937	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	159867	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2153478	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1600636	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3189851	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7841533	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11026971	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12349673	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	484335	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	714068	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	556000	usd
CY2023Q4	RELI	Warrant Liabilities WarrantLiabilities	268993	usd
CY2022Q4	RELI	Warrant Liabilities WarrantLiabilities	6433150	usd
CY2023Q4	us-gaap	Liabilities Liabilities	15867679	usd
CY2022Q4	us-gaap	Liabilities Liabilities	29516690	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.086
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.086
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	750000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	750000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.086
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.086
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4761974	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4761974	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1219573	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1219573	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	409509	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	104883	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45739786	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35798139	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39001965	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26991983	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7147330	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8911039	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23015009	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38427729	usd
CY2023	RELI	Commission Income CommissionIncome	13731826	usd
CY2022	RELI	Commission Income CommissionIncome	11761882	usd
CY2023	us-gaap	Revenues Revenues	13731826	usd
CY2022	us-gaap	Revenues Revenues	11761882	usd
CY2023	RELI	Commission Expense CommissionExpense	3732939	usd
CY2022	RELI	Commission Expense CommissionExpense	3140725	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	7503052	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	7508312	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4089989	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4959151	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	364974	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	170311	usd
CY2023	RELI	Change In Estimated Acquisition Earnout Payables ChangeInEstimatedAcquisitionEarnoutPayables	1716873	usd
CY2022	RELI	Change In Estimated Acquisition Earnout Payables ChangeInEstimatedAcquisitionEarnoutPayables	524	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2609191	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2563518	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7594000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	27611018	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	18342541	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-13879192	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6580659	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6530	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4341	usd
CY2023	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	5503647	usd
CY2022	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	29064958	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3853924	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28142591	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-10025268	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	21561932	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1984714	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-15095770	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-12009982	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6466162	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.46
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	13.36
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.70
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-13.78
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.16
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-4.46
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	13.36
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.70
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-13.78
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.16
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2820275	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1094781	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2820275	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1094989	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8911039	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	875106	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3001045	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	645000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3446484	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	589860	usd
CY2023	RELI	Common Shares Issued For Series B Warrants Value CommonSharesIssuedForSeriesBWarrantsValue	660510	usd
CY2023	RELI	Common Shares Issued For Series E Warrants Value CommonSharesIssuedForSeriesEWarrantsValue	-1704	usd
CY2023	RELI	Common Shares Issued For Series F Warrants Value CommonSharesIssuedForSeriesFWarrantsValue	1029972	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-12009982	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7147330	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-26066129	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1249873	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000051	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4763451	usd
CY2022	RELI	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2475000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1336	usd
CY2022	RELI	Stock Issued During Period Value Conversion Of Units Series D StockIssuedDuringPeriodValueConversionOfUnitsSeriesD	795	usd
CY2022	RELI	Stock Issued During Period Value Conversion Of Units Series B StockIssuedDuringPeriodValueConversionOfUnitsSeriesB	12500	usd
CY2022	RELI	Warrant Liability Reclassified To Equity Upon Exercise Of Series B Warrants WarrantLiabilityReclassifiedToEquityUponExerciseOfSeriesBWarrants	8000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6466162	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6466162	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8911039	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8911039	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-12009982	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6466162	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2609191	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2563518	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7594000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	46883	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	41875	usd
CY2023	RELI	Noncash Lease Expense NoncashLeaseExpense	-5377	usd
CY2022	RELI	Noncash Lease Expense NoncashLeaseExpense	21452	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	875106	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1249873	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	397049	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5503647	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-29064958	usd
CY2023	RELI	Change In Estimated Acquisition Earnout Payables ChangeInEstimatedAcquisitionEarnoutPayables	1716873	usd
CY2022	RELI	Change In Estimated Acquisition Earnout Payables ChangeInEstimatedAcquisitionEarnoutPayables	524	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	304542	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-123096	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-11689	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	11161	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-10565	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	11464	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-104590	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2501023	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-2992	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6492	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-48266	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1811237	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-93699	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	269613	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4596575	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-17668176	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	3748605	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	14478179	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-847970	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3189997	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22864	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61454	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	166947	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	740922	usd
CY2023	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	900000	usd
CY2022	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	450000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	710189	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-6352376	usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-18289936	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	710189	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24642312	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	1090622	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	875010	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	214257	usd
CY2022	RELI	Proceeds From Loan Acquired Through Acquisition ProceedsFromLoanAcquiredThroughAcquisition	6520000	usd
CY2022	RELI	Isusance Of Common Shares In Exchange For Series B Warrants IsusanceOfCommonSharesInExchangeForSeriesBWarrants	12500	usd
CY2022	RELI	Isusance Of Common Shares In Exchange For Series C Warrants IsusanceOfCommonSharesInExchangeForSeriesCWarrants	2131	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	241975	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	322095	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	310383	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1045164	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	184252	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-855000	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1500000	usd
CY2023	RELI	Payments On Earnout Liabilities PaymentsOnEarnoutLiabilities	419225	usd
CY2022	RELI	Payments On Earnout Liabilities PaymentsOnEarnoutLiabilities	1704924	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1028270	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2475000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3446484	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	17853351	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	984623	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	25074156	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-17700	usd
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	47200	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	966923	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25121356	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	829142	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2710953	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1909769	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4620722	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2738911	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1909769	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1612829	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	863936	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	645000	usd
CY2023	RELI	Common Shares Issued For Earnout Liabilities CommonSharesIssuedForEarnoutLiabilities	3001045	usd
CY2023	RELI	Common Shares Issued For Series B Warrants CommonSharesIssuedForSeriesBWarrants	660510	usd
CY2022	RELI	Common Shares Issued For Series B Warrants CommonSharesIssuedForSeriesBWarrants	8000	usd
CY2022	RELI	Common Shares Issued For Series D Warrants CommonSharesIssuedForSeriesDWarrants	36761	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	190069	usd
CY2023	RELI	Common Stock Issued For Prepaid Assets CommonStockIssuedForPrepaidAssets	192811	usd
CY2022	RELI	Issuance Of Series D Warrants IssuanceOfSeriesDWarrants	6930335	usd
CY2022	RELI	Issuance Of Placement Agent Warrants IssuanceOfPlacementAgentWarrants	1525923	usd
CY2022	RELI	Acquisition Of Business Deferred Purchase Price Liability AcquisitionOfBusinessDeferredPurchasePriceLiability	1125000	usd
CY2023	RELI	Lease Assets Acquired In Exchange For Lease Liabilities LeaseAssetsAcquiredInExchangeForLeaseLiabilities	156542	usd
CY2022	RELI	Lease Assets Acquired In Exchange For Lease Liabilities LeaseAssetsAcquiredInExchangeForLeaseLiabilities	310146	usd
CY2022	RELI	Noncash Investing And Financing Transactions Discontinued Operations NoncashInvestingAndFinancingTransactionsDiscontinuedOperations	5081309	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2739000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4379000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3190000	usd
CY2023Q4	RELI	Working Capital Deficiency WorkingCapitalDeficiency	-1189000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7147000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-13879000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7594000	usd
CY2023	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	5504000	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	1650000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10025000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1985000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-12010000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	3446000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zkLNCy4qCfn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z1c1VMBVR4ta">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Cash	1329016	usd
CY2022Q4	us-gaap	Cash Cash	505410	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1409895	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1404359	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2738911	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1909769	usd
CY2021Q4	RELI	Warrant Liabilities WarrantLiabilities	37652808	usd
CY2022	RELI	Initial Recognition Of Warrant Commitment InitialRecognitionOfWarrantCommitment	56587043	usd
CY2022	RELI	Warrant Commitment Unrealized Gain Loss WarrantCommitmentUnrealizedGainLoss	-32737582	usd
CY2022	RELI	Warrants Exercised Or Transferred WarrantsExercisedOrTransferred	-55069119	usd
CY2022Q4	RELI	Warrant Liabilities WarrantLiabilities	6433150	usd
CY2022Q4	RELI	Warrant Liabilities WarrantLiabilities	6433150	usd
CY2023	RELI	Warrant Commitment Unrealized Gain Loss WarrantCommitmentUnrealizedGainLoss	-5583506	usd
CY2023	RELI	Warrants Exercised Or Transferred WarrantsExercisedOrTransferred	-580651	usd
CY2023Q4	RELI	Warrant Liabilities WarrantLiabilities	268993	usd
CY2022	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	29064958	usd
CY2022	RELI	Warrant Issuance Cost WarrantIssuanceCost	3672624	usd
CY2023	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	5503647	usd
CY2023	RELI	Warrant Issuance Cost WarrantIssuanceCost	79859	usd
CY2023Q4	RELI	Earn Out Payments EarnOutPayments	165000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2709478	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3813878	usd
CY2023	RELI	Acquisitions And Settlements AcquisitionsAndSettlements	-3260403	usd
CY2022	RELI	Acquisitions And Settlements AcquisitionsAndSettlements	-1104924	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1716873	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	524	usd
CY2023	RELI	Earnout Payable In Common Shares EarnoutPayableInCommonShares	-159867	usd
CY2023	RELI	Earnout Transferred To Loans Payable Related Parties EarnoutTransferredToLoansPayableRelatedParties	-846214	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	159867	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2709478	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	159867	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2153478	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	556000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	273864	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	313829	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13731826	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11761882	usd
CY2023Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	2761190	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	278380	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	255801	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	138381	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	93034	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139999	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	162767	usd
CY2023	us-gaap	Depreciation Depreciation	45632	usd
CY2022	us-gaap	Depreciation Depreciation	37638	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7594000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	10050277	usd
CY2022Q4	us-gaap	Goodwill Goodwill	14287099	usd
CY2023Q4	us-gaap	Goodwill Goodwill	6693099	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1	10050277	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1	19112733	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7594000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1	6693099	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19750417	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-8707660	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11042757	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19583603	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-6144234	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13439369	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2563559	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2525880	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2195191	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1801235	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1532267	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1196989	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1097825	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3218683	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11042757	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	635339	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	747469	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40540	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	109502	usd
CY2023Q4	RELI	Accrued Credit Card Payables AccruedCreditCardPayables	54416	usd
CY2022Q4	RELI	Accrued Credit Card Payables AccruedCreditCardPayables	58120	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	105188	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36291	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	835483	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	951382	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	12417737	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	13468394	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1390766	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1118721	usd
CY2023Q4	RELI	Long Term Debt Net LongTermDebtNet	11026971	usd
CY2022Q4	RELI	Long Term Debt Net LongTermDebtNet	12349673	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1390766	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1552772	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1729160	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1925603	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2107128	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3986172	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	12691601	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	273864	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	12417737	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	181000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	482000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.1275	pure
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0	pure
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	56000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	154000	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	17408311	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	750000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.086
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.086
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4761974	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1219573	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	The aggregate purchase price for the Common Shares, Prefunded Warrants (Series E Warrants) and the Common Warrants (Series F Warrants) to be purchased by the Buyer shall be equal to (i) $3.80 for each Common Unit purchased by such Buyer, or (ii) $3.799 for each Prefunded Unit purchased by the Buyer, which Prefunded Warrants are exercisable into Prefunded Warrant Shares at the initial Exercise Price (as defined in the Prefunded Warrant) of $0.001 per Prefunded Warrant Share in accordance with the Prefunded Warrant.
CY2023Q4	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	1.12	pure
CY2023Q4	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0423	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10928	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	232.55
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y7M9D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10928	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	232.55
CY2023	RELI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P0Y7M9D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10928	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	232.55
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7M9D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10928	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	232.55
CY2022	RELI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P1Y7M9D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	271	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	236.83
CY2023	RELI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Non Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermNonVested	P2Y3M7D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	248	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	239.68
CY2023	RELI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTerm2	P0Y9M21D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	23	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	205.70
CY2023	RELI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Terms Non Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermsNonVested	P1Y7M2D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	3587	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	227.78
CY2022	RELI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Non Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermNonVested	P0Y10M24D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	3315	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	14.89
CY2022	RELI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTerm2	P1Y8M15D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	271	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	236.83
CY2022	RELI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Terms Non Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermsNonVested	P2Y3M7D
CY2023	RELI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitures	0	usd
CY2022	RELI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitures	0	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	2421960	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1542	usd
CY2023Q4	RELI	Market Value Of Share MarketValueOfShare	0.54
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	2421960	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	17166	usd
CY2022Q4	RELI	Market Value Of Share MarketValueOfShare	8.55
CY2023	RELI	Stock Issued During Period Shares Commission Equity Award Expense StockIssuedDuringPeriodSharesCommissionEquityAwardExpense	22221	shares
CY2022	RELI	Stock Issued During Period Shares Commission Equity Award Expense StockIssuedDuringPeriodSharesCommissionEquityAwardExpense	0	shares
CY2023	RELI	Stock Issued During Period Value Commission Equity Award Expense StockIssuedDuringPeriodValueCommissionEquityAwardExpense	276400	usd
CY2022	RELI	Stock Issued During Period Value Commission Equity Award Expense StockIssuedDuringPeriodValueCommissionEquityAwardExpense	249650	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	875000	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1250000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10025268	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	21561932	usd
CY2023	RELI	Deemed Dividends DeemedDividends	-2539757	usd
CY2022	RELI	Deemed Dividends DeemedDividends	-6930335	usd
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-12565025	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	14631597	usd
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-12565025	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	14631597	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2820275	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1094781	shares
CY2022	RELI	Effect Of Weighted Average Vested Stock Awards EffectOfWeightedAverageVestedStockAwards	208	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2820275	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1094989	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.46
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	13.36
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-4.46
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	13.36
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	534404	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	598422	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M1D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0608	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M25D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0567	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	320420	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	153831	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	113738	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	117150	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	120665	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	30387	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	856191	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	86685	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	769506	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2709478	usd
CY2023	RELI	Changes Due To Payments ChangesDueToPayments	-3260403	usd
CY2023	RELI	Changes Due To Fair Value Adjustments ChangesDueToFairValueAdjustments	1716873	usd
CY2023	RELI	Changes Due To Amount Payable In Common Shares ChangesDueToAmountPayableInCommonShares	-159867	usd
CY2023	RELI	Reclass To Loans Payable Related Parties ReclassToLoansPayableRelatedParties	-846214	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	159867	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3813878	usd
CY2022	RELI	Changes Due To Business Combinations ChangesDueToBusinessCombinations	600000	usd
CY2022	RELI	Changes Due To Payments ChangesDueToPayments	-1704924	usd
CY2022	RELI	Changes Due To Fair Value Adjustments ChangesDueToFairValueAdjustments	524	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2709478	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.089	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.079	pure
CY2023	RELI	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Commitment EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantCommitment	0.093	pure
CY2022	RELI	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Commitment EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantCommitment	-1.063	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.118	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.467	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.002	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.041	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	-0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	-0.022	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.509	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.485	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10399616	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4938164	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1462901	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1148836	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	332159	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	771631	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	694358	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	745227	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	151775	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	99002	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	186905	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	300616	usd
CY2023Q4	RELI	Deferred Tax Liabilities Lease Liabilities DeferredTaxLiabilitiesLeaseLiabilities	194403	usd
CY2022Q4	RELI	Deferred Tax Liabilities Lease Liabilities DeferredTaxLiabilitiesLeaseLiabilities	313342	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4027	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1525	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12084466	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5975846	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12084466	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5975846	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	41300000	usd
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	Federal Net Operating Loss Carry forwards, of which $1.3 million will begin to expire beginning 2031
CY2023	RELI	Income Tax Expiration Date Description IncomeTaxExpirationDateDescription	$40.0 million will not expire but are limited to use of 80% of current year taxable income
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	34800000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6108620	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3140780	usd
CY2023Q1	RELI	Deferred Purchase Price DeferredPurchasePrice	1375000	usd
CY2023Q1	RELI	Accrue Interest Rate Percentage AccrueInterestRatePercentage	0.015	pure

Files In Submission

Name	View Source	Status
0001493152-24-013118-index-headers.html	Edgar Link	pending
0001493152-24-013118-index.html	Edgar Link	pending
0001493152-24-013118.txt	Edgar Link	pending
0001493152-24-013118-xbrl.zip	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
reli-20231231.xsd	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
reli-20231231_def.xml	Edgar Link	unprocessable
reli-20231231_pre.xml	Edgar Link	unprocessable
reli-20231231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
reli-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RELI
Reliance Global Group, Inc. Stock $reli

2024 Q2 Form 10-K Financial Statement

#000149315224013118 Filed on April 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RELI Reliance Global Group, Inc. Stock $reli

2024 Q2 Form 10-K Financial Statement

#000149315224013118 Filed on April 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RELI
Reliance Global Group, Inc. Stock $reli